Cholamandalam Financial Holdings LtdNSE: CHOLAHLDNG
Open the Cholamandalam Financial Holdings Ltd page
Follow Cholamandalam Financial Holdings LtdFree account. Get a note when Cholamandalam Financial Holdings Ltd files.
Q2 FY27 results analysis · November 06, 2026

Cholamandalam Financial Holdings Ltd (CHOLAHLDNG) Q2 FY27 Results Analysis: Disbursements Surge 47%, Insurance Slips to Loss

+25.2%PAT year on year, Rs. 1,520.11 Cr
Cofacto ResearchPublished November 06, 20265 min readPositive read
Quick summary

Cholamandalam Financial Holdings Ltd's Q2 FY27 numbers came in strong, with revenue of Rs. 11,388.41 Cr (+18.90% YoY) and PAT growth of +25.19% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateNovember 06, 2026
Revenue (Q2)Rs. 11,388.41 Cr (+18.90% YoY)
PAT (Q2)Rs. 1,520.11 Cr (+25.19% YoY)
EPS (Q2)Rs. 34.22 (+16.87% YoY)

Quarter Snapshot

Lending momentum is the story: CIFCL disbursements grew 47% YoY and AUM 23% YoY, at the top of the 20-23% guidance band, driving financing segment profit up 39.78% YoY with 270 bps margin expansion. The offset is the insurance segment flipping to a Rs.169.09 Cr pre-tax loss on NATCAT and Motor OD claims, plus a 22.78% QoQ employee-cost jump, which cut consolidated PAT 15.02% QoQ despite 25.19% YoY growth. H2 profitability targets (ROTA ≥4.2%, Chola MS ROE recovery) remain the binding questions rather than growth.

Q2 FY27 Expectations vs Results

DriverExpected before resultsWhat happenedVerdict
Growth vs guide"ahead to in-line" — accelerating system credit and record vehicle retails support the 22–23% AUM guideAUM +23% YoY (Rs.2,68,009 Cr); disbursements +47%Played out
Q2 margin bridge"NIM likely flat to modestly compressing… risk is forward"interest income +5.61% QoQ vs finance costs +8.16% QoQ; financing margin 23.59% vs 25.09% Q1 (NIM itself not disclosed in filing) — modest in-quarter compression, forward risk intactPartially
Chola MS cost headwindEOM paper + Shishu Pal ruling + motor OD tide "moving the other way"insurance segment PBT loss Rs.169.09 Cr; CMSGICL post-tax loss Rs.120 Cr on NATCAT + motor ODPlayed out
Cost-of-funds guide (~10 bps H2)"direction of risk is to the high side"finance costs +23.22% YoY, +8.16% QoQ — directionPlayed out
Watch: motor OD loss-ratio glide path (Q2 = first checkpoint)improvement expected over "couple of quarters"filing cites elevated motor OD claims; ratio not disclosedNot observable from the filing
Watch: incremental motor TP provisions / review petitionpeers took Q1 provisions; petition pendingnothing disclosed in the Q2 filing — remains open for the callNot addressed in the filing
Watch: EOM consultation read-through; IFRS preliminary observations (effective Apr 1, 2027)management assessment expected on the callfiling notes cover only labour codes and the Ind AS forbearance till Mar 31, 2027 — remains open for the callNot addressed in the filing

Read our full results preview.

Management Guidance vs Delivery

What management saidWhereWhat happenedVerdict
CIFCL AUM growth 20%–23% (FY27)Q4 FY26/Q1 FY27 earnings calls ("still holding to the 22-23% growth guidance")AUM Rs.2,68,009 Cr, +23% YoYOn Track
CIFCL disbursement growth 12%–15% (FY27)Q4 FY26 earnings callQ2 disbursements Rs.35,872 Cr, +47% YoYOn Track
CIFCL net NPA 1.5% by FY27-endCIFCL management commentary, Q1 FY27achieved in Q1 FY27, ahead of goal (per prior-quarter disclosures); not re-disclosed this quarterMet
Chola MS motor OD loss ratio to high-70s "within a couple of quarters"Q1 FY27 earnings callpress release cites "elevated claim experience in Motor OD segment"; ratio not disclosed — first checkpoint went the wrong wayToo Early
Chola MS ROE 16%–18% IGAAP medium-term; "15% plus" medium-to-long termQ2 FY26/Q4 FY26 earnings callsQ2 post-tax loss Rs.120 Cr; H1 PAT Rs.8 Cr vs Rs.165 Cr — trajectory currently adverseToo Early
Growth momentum intact across major businessesQ1 FY27 call (chairman's statement quoted in prior-quarter notes)Q2 disbursements +47%, AUM +23% (press release)Confirmed
No additional credit overlays requiredQ4 FY26 callimpairment on financial instruments fell 3.58% YoY / 6.18% QoQConfirmed
Insurance ROE recovery toward 16%–18%Q2 FY26/Q4 FY26 callsinsurance segment swung to a Rs.169.09 Cr PBT lossContradicted for now
Vehicle down-cycle turningQ4 FY26/Q1 FY27 callsnot testable from the consolidated filing — no vehicle-finance split disclosedToo Early

Key Numbers, Quarter by Quarter

MetricQ3 FY26Q4 FY26Q1 FY27Q2 FY27
CIFCL disbursement growth+16%+25%+22%+47%
CIFCL AUM growth+21%+21%+23%+23%
Chola MS GWP growthn.d.n.d.+6%+7%

Key Investment Insights

Key Positives

  • CIFCL disbursements grew 47% YoY to Rs.35,872 Cr in Q2, well ahead of the 12-15% FY27 guidance
  • CIFCL AUM grew 23% YoY to Rs.2,68,009 Cr, at the top of the 20-23% FY27 guidance band
  • Financing segment result grew 39.78% YoY to Rs.2,187.05 Cr with margin up 270 bps YoY to 23.59%
  • Consolidated PAT grew 25.19% YoY to Rs.1,520.11 Cr; H1 PAT grew 33.76% YoY
  • Fee & commission income grew 45.19% YoY to Rs.767.04 Cr
  • Impairment on financial instruments fell 3.58% YoY to Rs.865.27 Cr
  • Loan growth of 10.39% since March was funded with borrowings up 9.91%, including Rs.4,000 Cr of new subordinated liabilities

Risk Factors

  • Insurance segment flipped to a pre-tax loss of Rs.169.09 Cr (vs +Rs.61.94 Cr YoY) with Chola MS posting a Q2 post-tax loss of Rs.120.03 Cr on NATCAT events and elevated Motor OD claims
  • Net insurance claims grew 16.74% YoY against 9.54% gross premium growth and only 1.64% insurance segment revenue growth
  • Employee benefits expense rose 30.67% YoY and 22.78% QoQ, with the QoQ rise unexplained in the filing
  • PAT fell 15.02% QoQ and owners' PAT fell 20.27% QoQ
  • Finance costs grew 8.16% QoQ vs interest income +5.61%, an early spread-squeeze signature
  • NCI absorbed 57.73% of consolidated PAT (54.70% in Q2 FY26) due to the 60%-owned insurer's loss

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.